Open AccessIntralesional injection of triamcinolone acetonide for cavernous hemangiomas
Author(s) -
Wenyan Wang,
Luan-Hong Wang,
Guang Huang,
Zhenying Lin,
Han Chieh Lin
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000016986
Subject(s) - medicine , triamcinolone acetonide , hemangioma , magnetic resonance imaging , surgery , cavernous hemangiomas , venous malformation , radiology
Rationale: Cavernous hemangiomas referred to as venous malformations (VMs), are not true vascular tumors. The treatment of cavernous hemangiomas is controversial. Patient concerns: A five-year-old girl with a cavernous hemangioma on her right buttock had undergone surgery but recurred 1 month after the operation. Diagnoses: Cavernous hemangioma was diagnosed on the basis of physical examination, magnetic resonance imaging (MRI) and postoperative pathologic examination. Interventions: We treated her with intralesional injection of triamcinolone acetonide (TCA) for 8 times. Outcomes: She was cured and had no recurrence during the 3-month follow-up. Lessons: This prompts that TCA may provide a more effective and safer choice for the treatment of cavernous hemangiomas.